FDA CLEARS 53 NMEs IN 1996 -- AVERAGE APPROVAL TIME IS 20.5; NEUROPHARM DRUGS APPEAR READY FOR 1997 CLEARANCE: THREE PARKINSON's THERAPIES POISED FOR APPROVAL

06 Jan 1997

• By The Pink Sheet

Three Parkinson's disease therapies appear on track for approval in 1997, continuing the prominence of central nervous system drugs among products reaching the commercial stage.

FDA CLEARS 53 NMEs IN 1996 -- AVERAGE APPROVAL TIME IS 20.5; NEUROPHARM DRUGS APPEAR READY FOR 1997 CLEARANCE: THREE PARKINSON's THERAPIES POISED FOR APPROVAL

More from Archive

More from Pink Sheet